Literature DB >> 30798343

Peripapillary and macular morpho-vascular changes in patients with genetic or clinical diagnosis of autosomal dominant optic atrophy: a case-control study.

Amélia Martins1, Tiago M Rodrigues2,3,4, Mário Soares2, Michael-John Dolan5,6, Joaquim N Murta2,7, Rufino Silva2,7,8, João P Marques2,7,8.   

Abstract

PURPOSE: To evaluate the macular and peripapillary morpho-vascular changes in ADOA, using optical coherence tomography (OCT) and OCT angiography (OCTA).
METHODS: Prospectively defined, cross-sectional case-control study. Consecutive patients with a genetic or clinical diagnosis of ADOA along with age- and sex-matched controls were included. The radial peripapillary capillary (RPC) density and vessel density (VD) in the parafoveal superficial and deep capillary plexuses (SCP and DCP, respectively) were evaluated with OCTA. The ganglion cell complex (GCC) and retinal nerve fiber layer (RNFL) thickness were determined using structural OCT. We applied a previously validated customized macro (Fiji, SciJava Consortium) to compute RPC density. The remaining parameters were calculated by the built-in software. Non-parametric methods were used for data analysis. The target α level was 0.05, which was adjusted through Bonferroni's correction when multiple outcomes were tested.
RESULTS: Fifty-eight eyes (n = 29 control; n = 29 ADOA) from 30 subjects (mean age 42.43 ± 15.30 years; 37.93% male) were included. Parafoveal SCP VD, GCC thickness, RPC VD in the temporal quadrant, as well as RNFL thickness in the nasal and temporal quadrants were decreased in ADOA eyes (all p < 0.001). When only patients with genetically confirmed diagnosis were included, capillary dropout in the circumpapillary superior and inferior quadrants also became evident (both p < 0.001). The GCC/parafoveal SCP ratio was increased in ADOA, relatively to matched controls. In contrast, none of the circumpapillary morpho-vascular ratios was significantly different in ADOA eyes.
CONCLUSIONS: The microvascular and structural changes found in ADOA suggest that both the macular and peripapillary regions are involved, although the threshold for damage of the structural and vascular components may be different for each region. Larger series with longitudinal follow-up may validate OCTA biomarkers helpful for disease monitoring.

Entities:  

Keywords:  Autosomal dominant optic atrophy; Morpho-vascular changes; Optical coherence tomography angiography; Parafoveal capillary plexus; Radial peripapillary capillary

Mesh:

Year:  2019        PMID: 30798343     DOI: 10.1007/s00417-019-04267-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

Review 1.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

2.  Optic nerve head microcirculation in autosomal dominant optic atrophy and normal-tension glaucoma.

Authors:  Noriko Himori; Hiroshi Kunikata; Maki Inoue; Takayuki Takeshita; Koji M Nishiguchi; Toru Nakazawa
Journal:  Acta Ophthalmol       Date:  2017-01-30       Impact factor: 3.761

3.  Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.

Authors:  E Pretegiani; F Rosini; A Rufa; G N Gallus; E Cardaioli; P Da Pozzo; S Bianchi; V Serchi; M Collura; R Franceschini; S Bianchi Marzoli; M T Dotti; A Federico
Journal:  J Neurol Sci       Date:  2017-09-14       Impact factor: 3.181

4.  The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma.

Authors:  Fumihiko Mabuchi; Sa Tang; Kenji Kashiwagi; Zentaro Yamagata; Hiroyuki Iijima; Shigeo Tsukahara
Journal:  Am J Ophthalmol       Date:  2006-10-23       Impact factor: 5.258

5.  A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene.

Authors:  Tin Aung; Louise Ocaka; Neil D Ebenezer; Alex G Morris; Michael Krawczak; Dawn L Thiselton; Christiane Alexander; Marcela Votruba; Glen Brice; Anne H Child; Peter J Francis; Roger A Hitchings; Ordan J Lehmann; Shomi S Bhattacharya
Journal:  Hum Genet       Date:  2001-11-23       Impact factor: 4.132

6.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.

Authors:  C Alexander; M Votruba; U E Pesch; D L Thiselton; S Mayer; A Moore; M Rodriguez; U Kellner; B Leo-Kottler; G Auburger; S S Bhattacharya; B Wissinger
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

7.  Optical Coherence Tomography Angiography of the Peripapillary Retina in Glaucoma.

Authors:  Liang Liu; Yali Jia; Hana L Takusagawa; Alex D Pechauer; Beth Edmunds; Lorinna Lombardi; Ellen Davis; John C Morrison; David Huang
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

8.  Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.

Authors:  Xiaolei Wang; Chunhui Jiang; Tony Ko; Xiangmei Kong; Xiaobo Yu; Wang Min; Guohua Shi; Xinghuai Sun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-11       Impact factor: 3.117

9.  The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Ailbhe Burke; Peter W Sellar; Michael P Clarke; Lawrence Gnanaraj; Desiree Ah-Kine; Gavin Hudson; Birgit Czermin; Robert W Taylor; Rita Horvath; Patrick F Chinnery
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

10.  OPA1 increases the risk of normal but not high tension glaucoma.

Authors:  P Yu-Wai-Man; J D Stewart; G Hudson; R M Andrews; P G Griffiths; M K Birch; P F Chinnery
Journal:  J Med Genet       Date:  2009-07-05       Impact factor: 6.318

View more
  1 in total

Review 1.  OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface.

Authors:  Samuel Asanad; Isa Mohammed; Alfredo A Sadun; Osamah J Saeedi
Journal:  Ther Adv Ophthalmol       Date:  2020-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.